Polyplus-transfection granted Roche's Glycart Biotechnology subsidiary a non-exclusive license to use polyethylenimine technology for in vitro transfection research applications

Polyplus-transfection S.A.

France / Tools, Services, and Manufacturing

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Roche

Switzerland / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced